Carboplatin–oral etoposide personalised dosing in elderly non-small cell lung cancer patients
- 31 October 1998
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (11) , 1710-1714
- https://doi.org/10.1016/s0959-8049(98)00207-x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Single agent gemcitabine activity in non-small cell lung cancerLung Cancer, 1997
- Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II studyEuropean Journal Of Cancer, 1997
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Phase I/II study of carboplatin and oral etoposide with granulocyte-colony stimulating factor in advanced nonsmall cell lung cancerCancer, 1995
- Oral Etoposide and CarboplatinAmerican Journal of Clinical Oncology, 1995
- Quality of life assessment in individuals with lung cancer: Testing the Lung Cancer Symptom Scale (LCSS)European Journal Of Cancer, 1993
- Prolonged administration of oral etoposide in non-small-cell lung cancer: a phase II trial.Journal of Clinical Oncology, 1992
- Reporting results of cancer treatmentCancer, 1981